Literature DB >> 26339757

Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.

Funda Öztunç1, Sezen U Atik1, Aslı O Güneş1.   

Abstract

Rhabdomyoma is the most common cardiac tumour in children often associated with tuberous sclerosis. Arrhythmia caused by cardiac rhabdomyomas may be the initial sign of tuberous sclerosis. Rhabdomyomas unresponsive to other treatments could be successfully managed with everolimus, which has demonstrated benefit in tuberous sclerosis. We report a case of rhabdomyoma causing severe arrhythmia in a newborn managed successfully with everolimus.

Entities:  

Keywords:  Rhabdomyoma; arrhythmia; everolimus

Mesh：

Substances：

Year:  2015        PMID： 26339757     DOI： 10.1017/S1047951114002261

Source DB:  PubMed          Journal:  Cardiol Young        ISSN： 1047-9511            Impact factor:   1.093


  4 in total

1.  Successful use of sirolimus for refractory atrial ectopic tachycardia in a child with cardiac rhabdomyoma.

Authors:  Sanja Ninic; Marija Kalaba; Bosiljka Jovicic; Vladislav Vukomanovic; Sergej Prijic; Biljana Vucetic; Ruzica Kravljanac; Ana Vujic; Jovan Kosutic
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-19       Impact factor: 1.468

2.  Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications.

Authors:  Eyal Sagiv; Sathish Mallenahalli Chikkabyrappa; Jeffrey Conwell; Mark Lewin; Terrence Un Hoong Chun
Journal:  Ann Pediatr Cardiol       Date:  2022-06-14

Review 3.  Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex-A Systematic Review.

Authors:  Monika Sugalska; Anna Tomik; Sergiusz Jóźwiak; Bożena Werner
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390

4.  Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.

Authors:  Afshin Saffari; Ines Brösse; Adelheid Wiemer-Kruel; Bernd Wilken; Paula Kreuzaler; Andreas Hahn; Matthias K Bernhard; Cornelis M van Tilburg; Georg F Hoffmann; Matthias Gorenflo; Sven Hethey; Olaf Kaiser; Stefan Kölker; Robert Wagner; Olaf Witt; Andreas Merkenschlager; Andreas Möckel; Timo Roser; Jan-Ulrich Schlump; Antje Serfling; Juliane Spiegler; Till Milde; Andreas Ziegler; Steffen Syrbe
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.